1. Report Overview
1.1 Introduction to Biologics Market
1.1. Global Biologics Market Segmentation
1.2 Biologics Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.1.1 Impact of COVID 19 on Global Pharma Supply Chain
1.7.1.2 Worldwide air transportation availability and costs
1.7.1.3 Return of pharmaceutical manufacturing back to the US
1.7.1.4 Possible supply disruptions of drugs identified as potential treatments against COVID-19
1.7.1.5 Prescription refills
1.7.1.6 Impact of pharmaceutical companies in clinical need
1.7.1.7 Battle for cure
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Market Size Estimation
1.8 Frequently Asked Questions (FAQs)

2 Executive Summary

3 Market Overview

3.1 Drivers
3.1.1 Ability to command high prices
3.1.2 Aging population and the rise of chronic disease
3.1.3 Product launches will drive biologics market
3.1.4 Rise in prevalence of chronic diseases
3.2 Restraints
3.2.1 Difficulty in manufacturing biologics
3.2.2 Stringent regulatory process and high capital investment
3.2.3 High costs in the face of declining national healthcare budgets
3.3 Opportunities
3.3.1 Application of biologics in complex diseases
3.3.2 Rising demand for next generation biologics
3.3.3 Consolidation growing in the industry
3.3.4 Pleasant policy controls
3.3.5 Strong pipeline of biologics drugs
3.4 Challenges
3.4.1 Risk and damage to supply chain due to COVID-19
3.4.2 Development of promising biological molecule into an effective product
3.4.3 Biosimilars – both an opportunity and a threat
3.5 Trends
3.5.1 Growing strategic partnerships in China
3.5.2 Outsourcing strategies
3.6 Porter’s Five Forces Analysis
3.6.1 Competitive Rivalry - High
3.6.2 Threat of New Entrants - Low
3.6.3 Bargaining Power of Suppliers - Low
3.6.4 Bargaining Power of Buyers - Medium
3.6.5 Threat of Substitutes – Medium/Low
3.7 SWOT Analysis
3.7.1 Strengths
3.7.2 Weaknesses
3.7.3 Opportunities
3.7.4 Threats
3.8 PEST Analysis
3.8.1 Political
3.8.2 Economical
3.8.3 Social
3.8.4 Technological

4 Global Biologics Market Size Forecast 2020-2030 by Product Type
4.1 Global Biologics Market for Monoclonal Antibodies Segment: Revenue Forecast 2020-2030
4.1.1 Monoclonal Antibodies Sub-market: Scientific and Historical Background
4.1.1.1 Natural Antibodies: Key to the Immune System
4.1.1.2 From serum therapy to monoclonal antibodies
4.1.1.3 Humanising the mAb
4.1.1.4 MAbs have found success in treating autoimmune disorders, cancers and other diseases – Great potential for the future
4.1.1.5 MAbs for All? Technologies Come Off Patent
4.1.2 Global Biologics Market for Monoclonal Antibodies Segment: Recovery Forecasts (V,U, W, L)
4.1.3 Autoimmune mAbs
4.1.3.1 Humira – The World’s Best-Selling Prescription Drug
4.1.3.1.1 Expanded Indications for Humira
4.1.3.1.2 Biosimilar Adalimumab: Patents Protect Humira in Developed Markets for Now
4.1.4 Global Biologics Market for Humira Segment: Recovery Forecasts (V,U, W, L)
4.1.4.1 Remicade: A Treatment for Immune-mediated Inflammatory Diseases
4.1.4.1.1 Patent Dance in the US
4.1.4.1.2 Biosimilar Infliximab: Multiple Launches
4.1.5 Global Biologics Market for Remicade Segment: Recovery Forecasts (V,U, W, L)
4.1.5.1 Tysabri: Blockbuster Drug’s High Efficacy Offsets its Risks
4.1.6 Global Biologics Market for Tysabri Segment: Recovery Forecasts (V,U, W, L)
4.1.7 Oncology mAbs
4.1.7.1 Past Approvals
4.1.7.2 Rising Incidence of Cancer Will Drive Demand
4.1.7.3 Rituxan: The World’s Leading Anti-Cancer mAb
4.1.7.4 Biosimilar Rituximab: Two Candidates Await Approval in Europe
4.1.7.5 Avastin: Growing under CER, Through New Indications
4.1.7.5.1 Controversy over Off-Label Avastin use: Roche is Backed up by Incidents in India, and Opinion of EFPIA
4.1.7.5.2 Biosimilar Bevacizumab: Late Patent Expiry is a Blessing for Roche, Although Various Biosimilars in Development
4.1.8 Global Biologics Market for Avastin Segment: Recovery Forecasts (V,U, W, L)
4.1.8.1 Herceptin: Breast Cancer Blockbuster
4.1.8.1.1 Pricing Challenges in Emerging Markets
4.1.8.1.2 Roche Builds Franchise of Anti-HER2 mAbs Around Herceptin
4.1.8.1.3 Biosimilar Trastuzumab
4.1.9 Global Biologics Market for Herceptin Segment: Recovery Forecasts (V,U, W, L)
4.1.9.1 Kadcyla
4.1.9.1.1 Mixed Results from Different Clinical Trials
4.1.9.1.2 Kadcyla Sales Forecast 2020 -2030
4.1.10 Global Biologics Market for Kadcyla Segment: Recovery Forecasts (V,U, W, L)
4.1.10.1 Perjeta
4.1.10.1.1 Positive Results from Different Clinical Trials
4.1.11 Global Biologics Market for Perjeta Segment: Recovery Forecasts (V,U, W, L)
4.1.11.1 Opdivo: Big Potential for Bristol-Myer Squibb’s PD-1 Inhibitor
4.1.12 Global Biologics Market for Opdivo Segment: Recovery Forecasts (V,U, W, L)
4.1.12.1 Keytruda
4.1.13 Global Biologics Market for Keytruda Segment: Recovery Forecasts (V,U, W, L)
4.1.13.1.1 Good News and Bad News for NSCLC from CheckMate Trials
4.1.13.1.2 Cyramza (Eli Lilly): Approved in Three Additional Indications Since its First Approval in April 2014.
4.1.13.2 Oncology mAbs: New Approvals and Pipeline
4.1.13.2.1 Empliciti (Elotuzumab) by Bristol-Myers Squibb and AbbVie): Recently Approved
4.1.13.2.2 Unituxin (United Therapeutics) Receives FDA Approval March 2015
4.1.13.2.3 SAR3419 (coltuximab ravtansine) (anti-CD19, Sanofi)
4.2 Global Biologics Market for Vaccines Segment: Revenue Forecast 2020-2030
4.2.1 Global Biologics Market for Vaccines Segment: Recovery Forecasts (V,U, W, L)
4.3 Global Biologics Market for Protein Therapeutics Segment: Revenue Forecast 2020-2030
4.3.1 Global Biologics Market for Protein Therapeutics Segment: Recovery Forecasts (V,U, W, L)
4.3.2 Global Biologics Market for Insulin Sub Segment: Revenue Forecast 2020-2030
4.3.3 Global Biologics Market for Insulin Segment: Recovery Forecasts (V,U, W, L)
4.3.3.1 Lantus
4.3.4 Global Biologics Market for Lantus Segment: Recovery Forecasts (V,U, W, L)
4.3.4.1 NovoLog/NovoRapid
4.3.5 Global Biologics Market for Novolog Segment: Recovery Forecasts (V,U, W, L)
4.3.5.1 Humalog
4.3.6 Global Biologics Market for Humalog Segment: Recovery Forecasts (V,U, W, L)
4.3.6.1 Levemir
4.3.7 Global Biologics Market for Levemir Segment: Recovery Forecasts (V,U, W, L)
4.3.7.1 Apidra
4.3.8 Global Biologics Market for Apidra Segment: Recovery Forecasts (V,U, W, L)
4.3.9 Other Recombinant Hormones: Erythropoietins, G-CSF and Human Growth Hormone
4.3.10 Global Biologics Market for Other Recombinant Hormones Segment: Recovery Forecasts (V,U, W, L)
4.3.10.1 Erythropoietin
4.3.10.2 G-CSF
4.3.10.3 Human Growth Hormones
4.3.10.4 Plasma and Recombinant Coagulating Factors
4.3.11 Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment: Recovery Forecasts (V,U, W, L)
4.3.11.1 Interferons
4.3.12 Global Biologics Market for Interferons Segment: Recovery Forecasts (V,U, W, L)
4.3.12.1.1 Avonex
4.3.13 Global Biologics Market for Avonex Segment: Recovery Forecasts (V,U, W, L)
4.3.13.1.1 Rebif
4.3.14 Global Biologics Market for Rebif Segment: Recovery Forecasts (V,U, W, L)
4.3.14.1.1 Betaseron
4.3.14.1.2 Plegridy
4.3.14.2 Enzyme Replacement and Other Protein Therapies
4.3.15 Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment: Recovery Forecasts (V,U, W, L)
4.4 Global Biologics Market for Regenerative Medicines Segment: Revenue Forecast 2020-2030
4.4.1 Global Biologics Market for Regenerative Medicines Segment: Recovery Forecasts (V,U, W, L)
4.4.2 Stem Cell Therapies
4.4.2.1 Stem Cells: Scientific Breakdown
4.4.3 Stem Cell Therapies
4.4.3.1 Haematopoietic Stem Cell Transplantation:
4.4.3.2 From Procedures to Products: Cord Blood Stem Cell Approvals
4.4.4 Global Biologics Market for Stem Cell Therapy Segment: Recovery Forecasts (V,U, W, L)
4.4.4.1 Osteocel Plus: The Leading Stem Cell Orthobiologic
4.4.5 Global Biologics Market for Osteocel Plus Segment: Recovery Forecasts (V,U, W, L)
4.4.5.1 Trinity Evolution and Trinity Elite
4.4.5.1.1 Trinity Evolution and Trinity Elite Revenue Forecast to 2030
4.4.6 Global Biologics Market for Trinity Evolution & Trinity Elite Segment: Recovery Forecasts (V,U, W, L)
4.4.6.1.1 MSC-100-IV (Previously Known as Prochymal): World’s First Approved Stem Cell Drug Outside of South Korea
4.4.6.1.2 An Important Role to Play in the Future of HSCT, and also Wins Approval in Japan through Partner
4.4.6.1.3 CARTISTEM (MEDIPOST): The World’s First Allogeneic Stem Cell Drug
4.4.6.1.4 Hearticellgram-AMI (PharmaCell B.V.): One of the First Approved Cardiovascular Stem Cell Treatments in the World.
4.4.7 Tissue Engineering Therapies
4.4.7.1 Tissue Engineering – In Vitro Manipulation for Therapeutic Purposes
4.4.7.2 Current Status of the Market
4.4.8 Global Biologics Market for Tissue Engineered Products Segment: Recovery Forecasts (V,U, W, L)
4.4.8.1 Apligraf: The Leading Product
4.4.8.2 Apligraf’s role in Wound Healing
4.4.9 Global Biologics Market for Dermagraft Segment: Recovery Forecasts (V,U, W, L)
4.4.9.1 ReCell
4.4.9.2 MySkin and CyroSkin
4.4.10 Global Biologics Market for Apligraft Segment: Recovery Forecasts (V,U, W, L)
4.4.10.1 Dermagraft: Organogenesis Further Strengthens Position Through this 2014 Acquisition
4.4.11 Tissue Engineering Therapies Pipeline
4.4.11.1 NeoCart by Histogenics: Undergoing Phase 3 Trial for Knee Cartilage Repair
4.4.11.2 Extracorporeal Bio-Artificial Liver Therapy by Vital Therapies
4.4.11.3 StrataGraft by Stratatech Corporation Demonstrates Positive Top-Line Results
4.4.12 Gene Therapies
4.4.12.1 Gene Therapy: Historical and Scientific Background
4.4.12.2 Harnessing Infectivity: Viral Vectors in Gene Therapy
4.4.12.3 Approved Gene Therapy Products
4.4.12.3.1 Gendicine: The World’s First Commercial Gene Therapy Product
4.4.12.3.2 Oncorine: First Oncolytic Viral Therapy
4.4.12.3.3 Neovasculgen: Russia’s First Gene Therapy
4.4.12.3.4 Neovasculgen: Drop in Revenues in 2015, but HSCI Predicts Notable Increases as Product is Added to VED List
4.4.12.3.5 Glybera: The First Gene Therapy for Western Markets, Although Has Abandoned Hope of Receiving FDA-Approval
4.4.12.4 IMLYGIC
4.4.12.4.1 IMLYGIC: Clinical Trials and Development Efforts
4.4.13 Global Biologics Market for IMIGYLC Segment: Recovery Forecasts (V,U, W, L)
4.5 Global Biologics Market for Fusion Proteins Segment: Revenue Forecast 2020-2030
4.5.1 Scientific and Historical Background
4.5.1.1 Differentiating Fusion Proteins
4.5.2 Global Biologics Market for Fusion Proteins Segment: Recovery Forecasts (V,U, W, L)
4.5.3 Enbrel: The First FP to be Approved, in 1998
4.5.3.1 Gradually Approved for Additional Indications
4.5.3.2 Enbrel Granted Extended Patent Protection in the US, Patent has Expired in EU
4.5.3.3 Multiple Biosimilars Available in Emerging Markets
4.5.4 Global Biologics Market for Enbrel Segment: Recovery Forecasts (V,U, W, L)
4.5.5 Eylea: Blockbuster FP Treatment for Wet AMD
4.5.6 Global Biologics Market for Eylea Segment: Recovery Forecasts (V,U, W, L)
4.5.7 Fusion Proteins Pipeline
4.5.7.1 Sotatercept by Acceleron Pharma and Celgene Corporation - Currently Undergoing Eight Clinical Trials
4.5.7.2 Blisibimod (Anthera Pharmaceuticals) for the Treatment of Various Autoimmune Diseases, in Late Stage Development

5 Global Biologics Market Size Forecast 2020-2030 by Application Type
5.1 Global Biologics Market for Oncology Segment: Revenue Forecast 2020-2030
5.1.1 Global Biologics Market for Oncology Segment: Recovery Forecasts (V,U, W, L)
5.2 Global Biologics Market for Autoimmune Diseases Segment: Revenue Forecast 2020-2030
5.2.1 Global Biologics Market for Autoimmune Diseases Segment: Recovery Forecasts (V,U, W, L)
5.3 Global Biologics Market for Infectious Diseases Segment: Revenue Forecast 2020-2030
5.3.1 Global Biologics Market for Infectious Diseases Segment: Recovery Forecasts (V,U, W, L)
5.4 Global Biologics Market for Cardiovascular Disorders Segment: Revenue Forecast 2020-2030
5.4.1 Global Biologics Market for Cardiovascular Disorders Segment: Recovery Forecasts (V,U, W, L)
5.5 Global Biologics Market for Hematological Disorders Segment: Revenue Forecast 2020-2030
5.5.1 Global Biologics Market for Hematological Disorders Segment: Recovery Forecasts (V,U, W, L)
5.6 Global Biologics Market for Others Segment: Revenue Forecast 2020-2030
5.6.1 Global Biologics Market for Others Segment: Recovery Forecasts (V,U, W, L)

6 Global Biologics Market Size Forecast 2020-2030 by Manufacturing
6.1 Global Biologics Market for Outsourced Manufacturing Segment: Revenue Forecast 2020-2030
6.1.1 Global Biologics Market for Outsourced Manufacturing Segment: Recovery Forecasts (V,U, W, L)
6.2 Global Biologics Market for In-house Manufacturing Segment: Revenue Forecast 2020-2030
6.2.1 Global Biologics Market for In-house Manufacturing Segment: Recovery Forecasts (V,U, W, L)

7 Regional and Leading National Biologics Market Forecasts 2020-2030
7.1 Global Biologics Market by National Market Forecast 2020-2030
7.1.1 Global Biologics Market Forecast 2020-2030, Recovery Scenarios

8 North America
8.1 North America Biologics Market Forecast by Country, 2020-2030
8.2 North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
8.2.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
8.3 North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
8.3.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
8.4 North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
8.4.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
8.5 U.S. Biologics Market Forecast 2020-2030
8.5.1 U.S. Biologics Market: Recovery Scenarios
8.6 Canada Biologics Market Forecast 2020-2030
8.6.1 Canada Biologics Market: Recovery Scenarios

9 Europe
9.1 Europe Biologics Market Forecast by Country, 2020-2030
9.2 Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
9.2.1 Recovery Scenarios (V, U, W, L) Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
9.3 Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
9.3.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
9.4 Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
9.4.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
9.5 Germany Biologics Market Forecast 2020-2030
9.5.1 Germany Biologics Market: Recovery Scenarios
9.6 UK Biologics Market Forecast 2020-2030
9.6.1 UK Biologics Market: Recovery Scenarios
9.7 France Biologics Market Forecast 2020-2030
9.7.1 France Biologics Market: Recovery Scenarios
9.8 Italy Biologics Market Forecast 2020-2030
9.8.1 Italy Biologics Market: Recovery Scenarios
9.9 Spain Biologics Market Forecast 2020-2030
9.9.1 Spain Biologics Market: Recovery Scenarios
9.10 Russia Biologics Market Forecast 2020-2030
9.10.1 Russia Biologics Market: Recovery Scenarios
9.11 RoE Biologics Market Forecast 2020-2030
9.11.1 RoE Biologics Market: Recovery Scenarios

10 Asia-Pacific
10.1 Asia-Pacific Biologics Market Forecast by Country, 2020-2030
10.2 Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
10.2.1 Recovery Scenarios (V, U, W, L): Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
10.3 Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
10.3.1 Recovery Scenarios (V, U, W, L): Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
10.4 Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
10.4.1 Recovery Scenarios (V, U, W, L): Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
10.5 Japan Biologics Market Forecast 2020-2030
10.5.1 Japan Biologics Market: Recovery Scenarios
10.6 China Biologics Market Forecast 2020-2030
10.6.1 China Biologics Market: Recovery Scenarios
10.7 India Biologics Market Forecast 2020-2030
10.7.1 India Biologics Market: Recovery Scenarios
10.8 Australia Biologics Market Forecast 2020-2030
10.8.1 Australia Biologics Market: Recovery Scenarios
10.9 RoAP Biologics Market Forecast 2020-2030
10.9.1 RoAP Biologics Market: Recovery Scenarios

11 Latin America
11.1 Latin America Biologics Market Forecast by Country, 2020-2030
11.2 Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
11.2.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
11.3 Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
11.3.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
11.4 Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
11.4.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
11.5 Brazil Biologics Market Forecast 2020-2030
11.5.1 Brazil Biologics Market: Recovery Scenarios
11.6 Mexico Biologics Market Forecast 2020-2030
11.6.1 Mexico Biologics Market: Recovery Scenarios
11.7 RoLA Biologics Market Forecast 2020-2030
11.7.1 RoLA Biologics Market: Recovery Scenarios

12 Middle East and Africa
12.1 MEA Biologics Market Forecast by Country, 2020-2030
12.2 MEA Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
12.2.1 Recovery Scenarios (V, U, W, L): Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
12.3 MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
12.3.1 Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
12.4 MEA Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
12.4.1 Recovery Scenarios (V, U, W, L): Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
12.5 GCC Biologics Market Forecast 2020-2030
12.5.1 GCC Biologics Market: Recovery Scenarios
12.6 South Africa Biologics Market Forecast 2020-2030
12.6.1 South Africa Biologics Market: Recovery Scenarios
12.7 RoMEA Biologics Market Forecast 2020-2030
12.7.1 RoMEA Biologics Market: Recovery Scenarios

13 Leading Companies in the Biologics Market
13.1 GlaxoSmithKline Plc
13.1.1 GlaxoSmithKline Plc: Company Snapshot
13.1.2 GlaxoSmithKline Plc: Company Overview
13.1.3 GlaxoSmithKline Plc Financials, 2015-2019
13.1.4 GlaxoSmithKline Plc: Product Portfolio
13.1.5 GlaxoSmithKline Plc: Recent Developments
13.2 Johnson & Johnson Services, Inc
13.2.1 Johnson & Johnson Services, Inc: Company Snapshot
13.2.2 Johnson & Johnson Services, Inc: Company Overview
13.2.3 Johnson & Johnson Services, Inc Financials, 2015-2019
13.2.4 Johnson & Johnson Services, Inc: Product Portfolio
13.2.5 Johnson & Johnson Services, Inc: Recent Developments
13.3 Merck & Co
13.3.1 Merck & Co: Company Snapshot
13.3.2 Merck & Co: Company Overview
13.3.3 Merck & Co Financials, 2015-2019
13.3.4 Merck & Co: Product Portfolio
13.3.5 Merck & Co: Recent Developments
13.4 Novartis AG
13.4.1 Novartis AG: Company Snapshot
13.4.2 Novartis AG: Company Overview
13.4.3 Novartis AG Financials, 2015-2019
13.4.4 Novartis AG: Product Portfolio
13.4.5 Novartis AG: Recent Developments
13.5 Pfizer Inc
13.5.1 Pfizer Inc: Company Snapshot
13.5.2 Pfizer Inc: Company Overview
13.5.3 Pfizer Inc Financials, 2015-2019
13.5.4 Pfizer Inc: Product Portfolio
13.5.5 Pfizer Inc: Recent Developments
13.6 Sanofi S.A
13.6.1 Sanofi S.A: Company Snapshot
13.6.2 Sanofi S.A: Company Overview
13.6.3 Sanofi S.A Financials, 2015-2019
13.6.4 Sanofi S.A: Product Portfolio
13.6.5 Sanofi S.A: Recent Developments
13.7 Novo Nordisk A/S
13.7.1 Novo Nordisk A/S: Company Snapshot
13.7.2 Novo Nordisk A/S: Company Overview
13.7.3 Novo Nordisk A/S Financials, 2015-2019
13.7.4 Novo Nordisk A/S: Product Portfolio
13.7.5 Novo Nordisk A/S: Recent Developments
13.8 Takeda Pharmaceutical
13.8.1 Takeda Pharmaceutical: Company Snapshot
13.8.2 Takeda Pharmaceutical: Company Overview
13.8.3 Takeda Pharmaceutical Financials, 2015-2019
13.8.4 Takeda Pharmaceutical: Product Portfolio
13.8.5 Takeda Pharmaceutical: Recent Developments
13.9 Gilead Sciences Inc
13.9.1 Gilead Sciences Inc: Company Snapshot
13.9.2 Gilead Sciences Inc: Company Overview
13.9.3 Gilead Sciences Inc Financials, 2015-2019
13.9.4 Gilead Sciences Inc: Product Portfolio
13.9.5 Gilead Sciences Inc: Recent Developments
13.10 Alexion Pharmaceuticals, Inc
13.10.1 Alexion Pharmaceuticals, Inc: Company Snapshot
13.10.2 Alexion Pharmaceuticals, Inc: Company Overview
13.10.3 Alexion Pharmaceuticals, Inc Financials, 2015-2019
13.10.4 Alexion Pharmaceuticals, Inc: Product Portfolio
13.10.5 Alexion Pharmaceuticals, Inc: Recent Developments
13.11 UCB SA
13.11.1 UCB SA: Company Snapshot
13.11.2 UCB SA: Company Overview
13.11.3 UCB SA Financials, 2015-2019
13.11.4 UCB SA: Product Portfolio
13.11.5 UCB SA: Recent Developments
13.12 Samsung Biologics Co., Ltd
13.12.1 Samsung Biologics Co., Ltd: Company Snapshot
13.12.2 Samsung Biologics Co., Ltd: Company Overview
13.12.3 Samsung Biologics Co., Ltd Financials, 2015-2019
13.12.4 Samsung Biologics Co., Ltd: Product Portfolio
13.12.5 Samsung Biologics Co., Ltd: Recent Developments
13.13 NEKTAR THERAPEUTICS
13.13.1 NEKTAR THERAPEUTICS: Company Snapshot
13.13.2 NEKTAR THERAPEUTICS: Company Overview
13.13.3 NEKTAR THERAPEUTICS Inc. Financials, 2015-2019
13.13.4 NEKTAR THERAPEUTICS: Product Portfolio
13.13.5 NEKTAR THERAPEUTICS: Recent Developments
13.14 REGENERON PHARMACEUTICALS, INC.
13.14.1 REGENERON PHARMACEUTICALS, INC.: Company Snapshot
13.14.2 REGENERON PHARMACEUTICALS, INC.: Company Overview
13.14.3 REGENERON PHARMACEUTICALS, INC. Financials, 2015-2019
13.14.4 REGENERON PHARMACEUTICALS, INC.: Product Portfolio
13.14.5 REGENERON PHARMACEUTICALS, INC.: Recent Developments
13.15 BioMarin PHARMACEUTICALS, INC.
13.15.1 BioMarin PHARMACEUTICALS, INC.: Company Snapshot
13.15.2 BioMarin PHARMACEUTICALS, INC.: Company Overview
13.15.3 BioMarin PHARMACEUTICALS, INC. Financials, 2015-2019
13.15.4 BioMarin PHARMACEUTICALS, INC.: Product Portfolio
13.15.5 BioMarin PHARMACEUTICALS, INC.: Recent Developments
13.16 Biogen Inc.
13.16.1 Biogen Inc.: Company Snapshot
13.16.2 Biogen Inc.: Company Overview
13.16.3 Biogen Inc. Financials, 2015-2019
13.16.4 Biogen Inc.: Product Portfolio
13.16.5 Biogen Inc.: Recent Developments
13.17 BRISTOL-MYERS SQUIBB
13.17.1 BRISTOL-MYERS SQUIBB: Company Snapshot
13.17.2 BRISTOL-MYERS SQUIBB: Company Overview
13.17.3 BRISTOL-MYERS SQUIBB Financials, 2015-2019
13.17.4 BRISTOL-MYERS SQUIBB: Product Portfolio
13.17.5 BRISTOL-MYERS SQUIBB: Recent Developments
13.18 Biocon
13.18.1 Biocon: Company Snapshot
13.18.2 Biocon: Company Overview
13.18.3 Biocon Financials, 2015-2019
13.18.4 Biocon: Product Portfolio
13.18.5 Biocon: Recent Developments
13.19 Abbvie Inc
13.19.1 Abbvie Inc: Company Snapshot
13.19.2 Abbvie Inc: Company Overview
13.19.3 Abbvie Inc Financials, 2015-2019
13.19.4 Abbvie Inc: Product Portfolio
13.19.5 Abbvie Inc: Recent Developments
13.20 Amgen
13.20.1 Amgen: Company Snapshot
13.20.2 Amgen: Company Overview
13.20.3 Amgen Financials, 2015-2019
13.20.4 Amgen: Product Portfolio
13.20.5 Amgen: Recent Developments
13.21 AstraZeneca PLC
13.21.1 AstraZeneca PLC: Company Snapshot
13.21.2 AstraZeneca PLC: Company Overview
13.21.3 AstraZeneca PLC Financials, 2015-2019
13.21.4 AstraZeneca PLC: Product Portfolio
13.21.5 AstraZeneca PLC: Recent Developments
13.22 Eli Lilly
13.22.1 Eli Lilly: Company Snapshot
13.22.2 Eli Lilly: Company Overview
13.22.3 Eli Lilly Financials, 2015-2019
13.22.4 Eli Lilly: Product Portfolio
13.23 F. Hoffmann-La Roche Ltd
13.23.1 F. Hoffmann-La Roche Ltd: Company Snapshot
13.23.2 F. Hoffmann-La Roche Ltd: Company Overview
13.23.3 F. Hoffmann-La Roche Ltd Financials, 2015-2019
13.23.4 F. Hoffmann-La Roche Ltd: Product Portfolio
13.23.5 F. Hoffmann-La Roche Ltd: Recent Developments
13.24 ANAPTYSBIO, INC.
13.24.1 ANAPTYSBIO, INC.: Company Snapshot
13.24.2 ANAPTYSBIO, INC.: Company Overview
13.24.3 ANAPTYSBIO, INC. Financials, 2015-2019
13.24.4 ANAPTYSBIO, INC.: Product Portfolio
13.24.5 ANAPTYSBIO, INC.: Recent Developments

14 Conclusions
14.1 Leading Products in 2020
14.2 Leading Applications in 2020
14.3 Leading Manufacturing Type in 2020
14.4 Major Revenue Pockets to Look Out For
14.5 Biologics Market to Achieve Steady Growth Throughout the Forecast Period
14.6 Changes in Market Composition: mAbs to Become Leading Submarket
14.7 The Emergence of Biosimilars
14.8 Challenges for the Market

15 Glossary

List of Tables

Table 1 “V” Shaped Recovery: Global Biologics Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 2 “U” Shaped Recovery: Global Biologics Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 3 “W” Shaped Recovery: Global Biologics Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 4 “L” Shaped Recovery: Global Biologics Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 5 Global Biologics Market, 2020-2030 (US$ billion, CAGR %)
Table 6 Global Biologics Market Forecast by Product Type, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 7 Regions of an Antibody
Table 8 Natural Antibody Mechanisms of Action
Table 9 Global Biologics Market for Monoclonal Antibodies Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 10 “V” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 11 “U” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 12 “W” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 13 “L” Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 14 Conditions Treated
Table 15 Selected Biosimilar Adalimumab Candidates
Table 16 Global Biologics Market for Humira Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 17 “V” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 18 “U” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 19 “W” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 20 “L” Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 21 Global Biologics Market for Remicade Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 22 “V” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 23 “U” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 24 “W” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 25 “L” Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 26 Global Biologics Market for Tysabri Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 27 “V” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 28 “U” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 29 “W” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 30 “L” Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 31 Global Biologics Market for Avastin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 32 “V” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 33 “U” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 34 “W” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 35 “L” Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 36 Global Biologics Market for Herceptin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 37 “V” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 38 “U” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 39 “W” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 40 “L” Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 41 Global Biologics Market for Kadcyla Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 42 “V” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 43 “U” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 44 “W” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 45 “L” Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 46 Global Biologics Market for Perjeta Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 47 “V” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 48 “U” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 49 “W” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 50 “L” Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 51 Global Biologics Market for Opdivo Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 52 “V” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 53 “U” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 54 “W” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 55 “L” Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 56 Global Biologics Market for Keytruda Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 57 “V” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 58 “U” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 59 “W” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 60 “L” Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 61 FDA-Approved Indications for Cyramza
Table 62 Global Biologics Market for Vaccines Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 63 “V” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 64 “U” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 65 “W” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 66 “L” Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 67 Global Biologics Market for Protein Therapeutics Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 68 “V” Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 69 “U” Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 70 “W” Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 71 “L” Shaped Recovery: Global Biologics Systems Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 72 Global Biologics Market for Insulin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 73 “V” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 74 “U” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 75 “W” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 76 “L” Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 77 Global Biologics Market for Lantus Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 78 “V” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 79 “U” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 80 “W” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 81 “L” Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 82 Global Biologics Market for Novolog Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 83 “V” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 84 “U” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 85 “W” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 86 “L” Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 87 Global Biologics Market for Humalog Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 88 “V” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 89 “U” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 90 “W” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 91 “L” Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 92 Global Biologics Market for Levemir Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 93 “V” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 94 “U” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 95 “W” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 96 “L” Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 97 Global Biologics Market for Apidra Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 98 “V” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 99 “U” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 100 “W” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 101 “L” Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 102 Global Biologics Market for Other Recombinant Hormones Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 103 “V” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 104 “U” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 105 “W” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 106 “L” Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 107 Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 108 “V” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 109 “U” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 110 “W” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 111 “L” Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 112 Global Biologics Market for Interferons Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 113 “V” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 114 “U” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 115 “W” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 116 “L” Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 117 Global Biologics Market for Avonex Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 118 “V” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 119 “U” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 120 “W” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 121 “L” Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 122 Global Biologics Market for Rebif Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 123 “V” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 124 “U” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 125 “W” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 126 “L” Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 127 Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 128 “V” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 129 “U” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 130 “W” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 131 “L” Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 132 Global Biologics Market for Regenerative Medicines Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 133 “V” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 134 “U” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 135 “W” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 136 “L” Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 137 Potency and Source of Stem Cells
Table 138 Global Biologics Market for Stem Cell Therapy Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 139 “V” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 140 “U” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 141 “W” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 142 “L” Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 143 Global Biologics Market for Osteocel Plus Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 144 “V” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 145 “U” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 146 “W” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 147 “L” Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 148 Global Biologics Market for Trinity Evolution & Trinity Elite Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 149 “V” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 150 “U” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 151 “W” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 152 “L” Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 153 Global Biologics Market for Tissue Engineered Products Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 154 “V” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 155 “U” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 156 “W” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 157 “L” Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 158 Global Biologics Market for Apligraft Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 159 “V” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 160 “U” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 161 “W” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 162 “L” Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 163 “V” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 164 “U” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 165 “W” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 166 “L” Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 167 Global Biologics Market for Dermagraft Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 168 Global Biologics Market for IMIGYLC Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 169 “V” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 170 “U” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 171 “W” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 172 “L” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 173 Global Biologics Market for Fusion Proteins Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 174 “V” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 175 “U” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 176 “W” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 177 “L” Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 178 Amgen’s US Patents and Expiry Dates for Enbrel
Table 179 Global Biologics Market for Enbrel Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 180 “V” Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 181 “U” Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 182 “W” Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 183 “L” Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 184 Global Biologics Market for Eylea Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 185 “V” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 186 “U” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 187 “W” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 188 “L” Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 189 Global Biologics Market Forecast by Application Type, 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 190 Global Biologics Market for Oncology Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 191 “V” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 192 “U” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 193 “W” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 194 “L” Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 195 Global Biologics Market for Autoimmune Diseases Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 196 “V” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 197 “U” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 198 “W” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 199 “L” Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 200 Global Biologics Market for Infectious Diseases Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 201 “V” Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 202 “U” Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 203 “W” Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 204 “L” Shaped Recovery: Global Biologics Systems Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 205 Global Biologics Market for Cardiovascular Disorders Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 206 “V” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 207 “U” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 208 “W” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 209 “L” Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 210 Global Biologics Market for Hematological Disorders Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 211 “V” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 212 “U” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 213 “W” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 214 “L” Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 215 Global Biologics Market for Others Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 216 “V” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 217 “U” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 218 “W” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 219 “L” Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 220 Global Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 221 Global Biologics Market for Outsourced Manufacturing Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 222 “V” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 223 “U” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 224 “W” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 225 “L” Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 226 Global Biologics Market for In-house Manufacturing Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 227 “V” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 228 “U” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 229 “W” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 230 “L” Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
Table 231 Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
Table 232 “V” Shaped Recovery: Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
Table 233 “U” Shaped Recovery: Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
Table 234 “W” Shaped Recovery: Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
Table 235 “L” Shaped Recovery: Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
Table 236 North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 237 “V” Shaped Recovery: North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 238 “U” Shaped Recovery: North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 239 “W” Shaped Recovery: North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 240 “L” Shaped Recovery: North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 241 North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 242 “V” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 243 “U” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 244 “W” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 245 “L” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 246 North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 247 “V” Shaped Recovery: North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 248 “U” Shaped Recovery: North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 249 “W” Shaped Recovery: North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 250 “L” Shaped Recovery: North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 251 U.S. Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 252 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 253 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 254 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 255 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 256 Canada Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 257 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 258 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 259 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 260 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 261 Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 262 “V” Shaped Recovery: Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 263 “U” Shaped Recovery: Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 264 “W” Shaped Recovery: Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 265 “L” Shaped Recovery: Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 266 Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 267 “V” Shaped Recovery: Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 268 “U” Shaped Recovery: Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 269 “W” Shaped Recovery: Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 270 “L” Shaped Recovery: Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 271 Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 272 “V” Shaped Recovery: Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 273 “U” Shaped Recovery: Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 274 “W” Shaped Recovery: Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 275 “L” Shaped Recovery: Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 276 Germany Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 277 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 278 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 279 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 280 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 281 UK Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 282 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 283 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 284 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 285 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 286 France Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 287 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 288 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 289 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 290 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 291 Italy Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 292 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 293 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 294 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 295 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 296 Spain Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 297 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 298 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 299 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 300 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 301 Russia Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 302 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 303 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 304 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 305 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 306 RoE Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 307 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 308 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 309 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 310 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 311 Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 312 “V” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 313 “U” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 314 “W” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 315 “L” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 316 Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 317 “V” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 318 “U” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 319 “W” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 320 “L” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 321 Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 322 “V” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 323 “U” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 324 “W” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 325 “L” Shaped Recovery: Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 326 Japan Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 327 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 328 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 329 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 330 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 331 China Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 332 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 333 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 334 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 335 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 336 India Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 337 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 338 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 339 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 340 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 341 Australia Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 342 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 343 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 344 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 345 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 346 RoAP Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 347 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 348 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 349 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 350 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 351 Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 352 “V” Shaped Recovery: Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 353 “U” Shaped Recovery: Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 354 “W” Shaped Recovery: Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 355 “L” Shaped Recovery: Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 356 Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 357 “V” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 358 “U” Shaped Recovery: Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 359 “W” Shaped Recovery: Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 360 “L” Shaped Recovery: Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 361 Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 362 “V” Shaped Recovery: Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 363 “U” Shaped Recovery: Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 364 “W” Shaped Recovery: Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 365 “L” Shaped Recovery: Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 366 Brazil Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 367 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 368 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 369 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 370 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 371 Mexico Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 372 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 373 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 374 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 375 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 376 RoLA Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 377 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 378 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 379 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 380 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 381 MEA Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 382 “V” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 383 “U” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 384 “W” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 385 “L” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
Table 386 MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 387 “V” Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 388 “U” Shaped Recovery: MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 389 “W” Shaped Recovery: Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 390 “L” Shaped Recovery: MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
Table 391 MEA Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 392 “V” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 393 “U” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 394 “W” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 395 “L” Shaped Recovery: Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
Table 396 GCC Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 397 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 398 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 399 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 400 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 401 South Africa Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 402 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 403 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 404 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 405 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 406 RoMEA Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
Table 407 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
Table 408 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
Table 409 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
Table 410 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
Table 411 GlaxoSmithKline Plc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 412 GlaxoSmithKline Plc Product Portfolio
Table 413 GlaxoSmithKline Plc: Recent Developments
Table 414 Johnson & Johnson Services, Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 415 Johnson & Johnson Services, Inc Product Portfolio
Table 416 Johnson & Johnson Services, Inc: Recent Developments
Table 417 Merck & Co Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 418 Merck & Co Product Portfolio
Table 419 Merck & Co: Recent Developments
Table 420 Novartis AG Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 421 Novartis AG Product Portfolio
Table 422 Novartis AG: Recent Developments
Table 423 Pfizer Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 424 Pfizer Inc Product Portfolio
Table 425 Pfizer Inc: Recent Developments
Table 426 Sanofi S.A Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 427 Sanofi S.A Product Portfolio
Table 428 Sanofi S.A: Recent Developments
Table 429 Novo Nordisk A/S Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 430 Novo Nordisk A/S Product Portfolio
Table 431 Novo Nordisk A/S: Recent Developments
Table 432 Takeda Pharmaceutical Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 433 Takeda Pharmaceutical Product Portfolio
Table 434 Takeda Pharmaceutical: Recent Developments
Table 435 Gilead Sciences Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 436 Gilead Sciences Inc Product Portfolio
Table 437 Gilead Sciences Inc: Recent Developments
Table 438 Alexion Pharmaceuticals, Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 439 Alexion Pharmaceuticals, Inc Product Portfolio
Table 440 Alexion Pharmaceuticals, Inc: Recent Developments
Table 441 UCB SA Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 442 UCB SA Product Portfolio
Table 443 UCB SA: Recent Developments
Table 444 Samsung Biologics Co., Ltd Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 445 Samsung Biologics Co., Ltd Product Portfolio
Table 446 Samsung Biologics Co., Ltd: Recent Developments
Table 447 NEKTAR THERAPEUTICS Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 448 NEKTAR THERAPEUTICS Product Portfolio
Table 449 NEKTAR THERAPEUTICS: Recent Developments
Table 450 REGENERON PHARMACEUTICALS, INC. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 451 REGENERON PHARMACEUTICALS, INC. Product Portfolio
Table 452 REGENERON PHARMACEUTICALS, INC.: Recent Developments
Table 453 BioMarin PHARMACEUTICALS, INC. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 454 BioMarin PHARMACEUTICALS, INC.: Recent Developments
Table 455 Biogen Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 456 Biogen Inc. Product Portfolio
Table 457 Biogen Inc.: Recent Developments
Table 458 BRISTOL-MYERS SQUIBB Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 459 BRISTOL-MYERS SQUIBB Product Portfolio
Table 460 BRISTOL-MYERS SQUIBB: Recent Developments
Table 461 Biocon Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 462 Biocon Product Portfolio
Table 463 Biocon: Recent Developments
Table 464 Abbvie Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 465 Abbvie Inc Product Portfolio
Table 466 Abbvie Inc: Recent Developments
Table 467 Amgen Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 468 Amgen Product Portfolio
Table 469 Amgen: Recent Developments
Table 470 AstraZeneca PLC Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 471 AstraZeneca PLC Product Portfolio
Table 472 AstraZeneca PLC: Recent Developments
Table 473 Eli Lilly Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 474 Eli Lilly Product Portfolio
Table 475 F. Hoffmann-La Roche Ltd Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 476 F. Hoffmann-La Roche Ltd Product Portfolio
Table 477 F. Hoffmann-La Roche Ltd: Recent Developments
Table 478 ANAPTYSBIO, INC. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 479 ANAPTYSBIO, INC. Product Portfolio
Table 480 ANAPTYSBIO, INC.: Recent Developments
Table 481 FDA Approved Biosimilars